In this webinar, presented by Ali Qamar, Product Manager at Calpro, we take a deep-dive into a few of the most common arguments advocating for the use of self-tests, and we show how various studies support these claims.
Did you know that in the past few years, there has truly been a revolution in how patients with IBD are followed up and monitored? All of this started initially with online-based questionnaires to make it easier for the physicians to look at how symptoms developed over time. The final addition to this has been the Calprotectin self-tests that have been developed. With the recent pandemic, the need for distant patient management has become even more evident.
Listen to the webinar for more information about the benefits of CalproSmart self-test and find out how IBD patients can monitor their own disease.
Did you know that Calpro has developed a new Deep Link application?
The Deep Link app makes it possible to link CalproSmart with patient report apps, used in patient support programs.
The CalproSmart™ solution is validated and approved for self-testing, and is used for monitoring IBD treatment using a smart phone, trending the quantitative levels of Calprotectin, and improving patient quality of life.
